Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest CrisisKenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
Source: Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis (https://www.nytimes.com/2025/09/22/health/tylenol-autism-kenvue.html)